Skip to main content
. 2011 Feb 25;60(2):109–118. doi: 10.4097/kjae.2011.60.2.109

Fig. 10.

Fig. 10

(A) Sevoflurane (2.0%) enhancement of the currents evoked by the co-application of midazolam (1.5 nM) and GABA (5 µM) at the α1β2γ2L and α1β2γ2S GABAA receptors. MDZ: midazolam, Sevo: sevoflurane. The data is expressed as means ± SEMs (6 cells for γ2L and 4 cells for γ2S were used). (B) Sevoflurane (2.0%) enhancement of the currents evoked by the co-application of midazolam (15 nM) and GABA (5 µM) at the α1β2γ2L and α1β2γ2S GABAA receptors. MDZ: midazolam, Sevo: sevoflurane. The data is expressed as means ± SEMs (6 cells for γ2L and 3 cells for γ2S were used). *P value < 0.05, when compared with γL-form.